Increased numbers of committed myeloid progenitors but not primitive hematopoietic stem/progenitors in mice lacking STAT6 expression

Journal of Leukocyte Biology

Volumn 76, Issue 2, 2004, Pages 484-490

  Bunting, Kevin D ^a,b   Yu, Wen Mei ^a   Bradley, Heath L ^a   Haviernikova, Eleonora ^a   Kelly Welch, Ann E ^a   Keegan, Achsah D ^a,c   Qu, Cheng Kui ^a,b  

^a HOLLAND LABORATORY   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Hematopoiesis; Hematopoietic stem cell; Interleukin 4; Knockout mouse

Indexed keywords

CYTOKINE; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 4 RECEPTOR ALPHA; ONCOSTATIN M; STAT6 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; BONE MARROW; CELL CYCLE; CELL STIMULATION; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HOMOLOGOUS RECOMBINATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANIMALS; CELL COUNT; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; MICE; MICE, INBRED BALB C; MYELOID PROGENITOR CELLS; STAT6 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

ANIMALIA;

EID: 3442882153     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0903440     Document Type: Conference Paper

References (43)

1. Meraz, M. A., White, J. M., Sheehan, K. C., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., Carver-Moore, K., DuBois, R. N., Clark, R., Aguet, M., Schreiber, R. D. (1996) Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84, 431-442.
2. Durbin, J. E., Hackenmiller, R., Simon, M. C., Levy, D. E. (1996) Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443-450.
3. Park, C., Li, S., Cha, E., Schindler, C. (2000) Immune response in Stat2 knockout mice. Immunity 13, 795-804.
4. Kaplan, M. H., Sun, Y. L., Hoey, T., Grusby, M. J. (1996) Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382, 174-177.
5. Thierfelder, W. E., van Deursen, J. M., Yamamoto, K., Tripp, R. A., Sarawar, S. R., Carson, R. T., Sangster, M. Y., Vignali, D. A., Doherty, P. C., Grosveld, G. C., Ihle, J. N. (1996) Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382, 171-174.
6. Shimoda, K., van Deursen, J., Sangster, M. Y., Sarawar, S. R., Carson, R. T., Tripp, R. A., Chu, C., Quelle, F. W., Nosaka, T., Vignali, D. A., Doherty, P. C., Grosveld, G., Paul, W. E., Ihle, J. N. (1996) Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380, 630-633.
7. Kaplan, M. H., Schindler, U., Smiley, S. T., Grusby, M. J. (1996) Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4, 313-319.
8. Akira, S. (1999) Functional roles of STAT family proteins: lessons from knockout mice. Stem Cells 17, 138-146.
9. Hou, S. X., Zheng, Z., Chen, X., Perrimon, N. (2002) The Jak/STAT pathway in model organisms: emerging roles in cell movement. Dev. Cell 3, 765-778.
10. Zhu, J., Guo, L., Watson, C. J., Hu-Li, J., Paul, W. E. (2001) Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion. J. Immunol. 166, 7276-7281.
11. Wurster, A. L., Withers, D. J., Uchida, T., White, M. F., Grusby, M. J. (2002) Stat6 and IRS-2 cooperate in interleukin 4 (IL-4)-induced proliferation and differentiation but are dispensable for IL-4-dependent rescue from apoptosis. Mol. Cell. Biol. 22, 117-126.
12. Sonoda, Y. (1994) Interleukin-4-a dual regulatory factor in hematopoiesis. Leuk. Lymphoma 14, 231-240.
13. Ogo, T., Otsuka, T., Satoh, H., Chifu, Y., Nakano, T., Niho, Y. (1991) Effects of interleukin 4 on stromal cell-associated bone marrow culture. Exp. Hematol. 19, 899-904.
14. Sawada, K., Sato, N., Koike, T. (1995) Inhibition of GM-CSF production by recombinant human interleukin-4: negative regulator of hematopoiesis. Leuk. Lymphoma 19, 33-42.
15. Keller, U., Aman, M. J., Derigs, G., Huber, C., Peschel, C. (1994) Human interleukin-4 enhances stromal cell-dependent hematopoiesis: costimulation with stem cell factor. Blood 84, 2189-2196.
16. Snoeck, H. W., Lardon, F., Van Bockstaele, D. R., Peetermans, M. E. (1993) Effects of interleukin-4 on myelopoiesis: localization of the action of IL-4 in the CD34+HLA-DR+ + subset and distinction between direct and indirect effects of IL-4. Exp. Hematol. 21, 635-639.
17. Snoeck, H. W., Lardon, F., Lenjou, M., Nys, G., Van Bockstaele, D. R., Peetermans, M. E. (1993) Interferon-γ and interleukin-4 reciprocally regulate the production of monocytes/macrophages and neutrophils through a direct effect on committed monopotential bone marrow progenitor cells. Eur. J. Immunol. 23, 1072-1077.
18. Kaplan, M. H., Daniel, C., Schindler, U., Grusby, M. J. (1998) Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression. Mol. Cell. Biol. 18, 1996-2003.
19. Zhang, S., Lawless, V. A., Kaplan, M. H. (2000) Cytokine-stimulated T lymphocyte proliferation is regulated by p27Kip1. J. Immunol. 165, 6270-6277.
20. Kaplan, M. H., Chang, H. C., Cooper, S., Lee, Y., Broxmeyer, H. E. (2003) Distinct requirements for Stat4 and Stat6 in hematopoietic progenitor cell responses to growth factors and chemokines. J. Hematother. Stem Cell Res. 12, 401-408.
21. Broxmeyer, H. E., Bruns, H. A., Zhang, S., Cooper, S., Hangoc, G., McKenzie, A. N., Dent, A. L., Schindler, U., Naeger, L. K., Hoey, T., Kaplan, M. H. (2002) Th1 cells regulate hematopoietic progenitor cell homeostasis by production of oncostatin M. Immunity 16, 815-825.
22. Schwaller, J., Parganas, E., Wang, D., Cain, D., Aster, J. C., Williams, I. R., Lee, C. K., Gerthner, R., Kitamura, T., Frantsve, J., Anastasiadou, E., Loh, M. L., Levy, D. E., Ihle, J. N., Gilliland, D. G. (2000) Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. Mol. Cell 6, 693-704.
23. Tanaka, M., Hirabayashi, Y., Sekiguchi, T., Inoue, T., Katsuki, M., Miyajima, A. (2003) Targeted disruption of oncostatin M receptor results in altered hematopoiesis. Blood 102, 3154-3162.
24. Ramalho-Santos, M., Yoon, S., Matsuzaki, Y., Mulligan, R. C., Melton, D. A. (2002) "Stemness": transcriptional profiling of embryonic and adult stem cells. Science 298, 597-600.
25. Cheng, T., Rodrigues, N., Shen, H., Yang, Y., Dombkowski, D., Sykes, M., Scadden, D. T. (2000) Hematopoietic stem cell quiescence maintained by p21(cip1/waf1). Science 287, 1804-1808.
26. Ploemacher, R. E., van der Sluijs, J. P., Voerman, J. S., Brons, N. H. (1989) An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood 74, 2755-2763.
27. Qu, C. K., Yu, W. M., Azzarelli, B., Cooper, S., Broxmeyer, H. E., Feng, G. S. (1998) Biased suppression of hematopoiesis and multiple developmental defects in chimeric mice containing Shp-2 mutant cells. Mol. Cell. Biol. 18, 6075-6082.
28. Yu, W. M., Hawley, T. S., Hawley, R. G., Qu, C. K. (2003) Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling. Oncogene 22, 5995-6004.
29. Na, N. T., Traver, D., Weissman, I. L., Akashi, K. (2002) Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. J. Clin. Invest. 109, 1579-1585.
30. Chitnis, T., Najafian, N., Benou, C., Salama, A. D., Grusby, M. J., Sayegh, M. H., Khoury, S. J. (2001) Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J. Clin. Invest. 108, 739-747.
31. Finnegan, A., Grusby, M. J., Kaplan, C. D., O'Neill, S. K., Eibel, H., Koreny, T., Czipri, M., Mikecz, K., Zhang, J. (2002) IL-4 and IL-12 regulate proteoglycan-induced arthritis through Stat-dependent mechanisms. J. Immunol. 169, 3345-3352.
32. Matsukawa, A., Kaplan, M. H., Hogaboam, C. M., Lukacs, N. W., Kunkel, S. L. (2001) Pivotal role of signal transducer and activator of transcription (Stat)4 and Stat6 in the innate immune response during sepsis. J. Exp. Med. 193, 679-688.
33. Zhang, W. J., Koltun, W. A., Thompson, J. L., Tilberg, A. F., Galka, E., Poritz, L. S., Chorney, M. J. (2004) Human B lymphoblast cell lines defective of Stat6 signaling produce high levels of proinflammatory cytokines IL-12, TNFα and IFNγ. Int. J. Oncol. 24, 447-453.
34. Wang, H. Y., Zamorano, J., Keegan, A. D. (1998) A role for the insulin-interleukin (IL)-4 receptor motif of the IL-4 receptor α-chain in regulating activation of the insulin receptor substrate 2 and signal transducer and activator of transcription 6 pathways. Analysis by mutagenesis. J. Biol. Chem. 273, 9898-9905.
35. Ohara, J., Paul, W. E. (1987) Receptors for B-cell stimulatory factor-1 expressed on cells of haematopoietic lineage. Nature 325, 537-540.
36. Peschel, C., Paul, W. E., Ohara, J., Green, I. (1987) Effects of B cell stimulatory factor-1/interleukin 4 on hematopoietic progenitor cells. Blood 70, 254-263.
37. Broxmeyer, H. E., Lu, L., Cooper, S., Tushinski, R., Mochizuki, D., Rubin, B. Y., Gillis, S., Williams, D. E. (1988) Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions. J. Immunol. 141, 3852-3862.
38. Musashi, M., Clark, S. C., Sudo, T., Urdal, D. L., Ogawa, M. (1991) Synergistic interactions between interleukin-11 and interleukin-4 in support of proliferation of primitive hematopoietic progenitors of mice. Blood 78, 1448-1451.
39. Schorle, H., Holtschke, T., Hunig, T., Schimpl, A., Horak, I. (1991) Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352, 621-624.
40. Barmeyer, C., Horak, I., Zeitz, M., Fromm, M., Schulzke, J. D. (2002) The interleukin-2-deficient mouse model. Pathobiology 70, 139-142.
41. Suzuki, H., Zhou, Y. W., Kato, M., Mak, T. W., Nakashima, I. (1999) Normal regulatory α/β T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor β in vivo. J. Exp. Med. 190, 1561-1572.
42. Chen, J., Astle, C. M., Harrison, D. E. (2002) Hematopoietic stem cell functional failure in interleukin-2-deficient mice. J. Hematother. Stem Cell Res. 11, 905-912.
43. Grossman, W. J., Verbsky, J. W., Yang, L., Berg, L. J., Fields, L. E., Chaplin, D. D., Ratner, L. (1999) Dysregulated myelopoiesis in mice lacking Jak3. Blood 94, 932-939.